Q&A: Lundbeck’s head of R&D on letting ‘biology speak’ in neuroscience

Johan Luthman has been running R&D at Lundbeck since 2019, and part of the neuroscience leader’s remit is helping steer development of a promising but still-experimental seizure medication that the company acquired last year in ...

Apr 8, 2025 - 15:02
 0
Q&A: Lundbeck’s head of R&D on letting ‘biology speak’ in neuroscience
Johan Luthman has been running R&D at Lundbeck since 2019, and part of the neuroscience leader’s remit is helping steer development of a promising but still-experimental seizure medication that the company acquired last year in ...